No BS RX review

This is the clearest low-dose structure of any provider we review. The catalog is split in two and the halves are labeled on the page, the pricing page opens on a toggle between microdosing and macrodosing, and three low-dose programs sit under their own heading — injectable semaglutide, injectable tirzepatide and an oral. Each is priced beneath the standard version of the same product, and the tirzepatide gap is the widest gap between a small dose and a standard one anywhere here. Everything is published before intake, on one page, with prepay totals printed beside monthly rates, and four dispensing pharmacies are named in the terms with street addresses and telephone numbers, which most sellers here do not manage. Two things are worth knowing before committing. The twelve-week rung is the same figure on all three low-dose programs no matter what the monthly rate is, which on either injectable makes prepaying twelve weeks worth about eleven dollars — worth checking rather than assuming. And the low-dose tier stops at twelve weeks: the deeper prepay rungs exist only on the standard side, so the biggest discounts are closed to you precisely because you are taking less. No milligram is published for either tier, so the labels are the whole description of the difference.

Vs median

$29/mo below the $169 median across the 261 of 407 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

No BS RX says it uses a 503A pharmacy, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.

No BS RX splits its catalog in two and labels the halves on the page: a standard tier and a low-dose tier, with a toggle at the top of the pricing page that switches between microdosing and macrodosing. Three low-dose programs sit under their own heading, each priced beneath the standard version of the same product, and every program row states the same three things — that the price does not change with the dose inside that program, that a licensed provider reviews the request, and that a 503A pharmacy fills it. The whole price list is published before any intake. Four dispensing pharmacies are named in the terms with street addresses and telephone numbers, and no operating company is named anywhere.

The twelve-week rung is $409 on all three low-dose programs whatever the monthly rate — so on either injectable it saves $11 across twelve weeks against paying monthly, a discount small enough to be worth checking before committing

• The low-dose programs stop at twelve weeks: the twenty-four and fifty-two week rungs exist only on the standard tier, so the deepest prepay discounts are closed to a low-dose buyer
• No milligram is published for any program, so what separates low-dose from standard is stated only as a label
• The terms name no operating company and no address for the business itself, only for the four pharmacies
• Which of the four pharmacies fills a given order is never stated
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

No BS RX is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Low dose vs full dose
• What microdosing GLP-1 costs
• Microdosing tirzepatide
• The true annual cost of a plan
• Microdose & reconstitution calculator